A modular analysis of bile canalicular function and its implications for cholestasis.


Journal

American journal of physiology. Gastrointestinal and liver physiology
ISSN: 1522-1547
Titre abrégé: Am J Physiol Gastrointest Liver Physiol
Pays: United States
ID NLM: 100901227

Informations de publication

Date de publication:
01 07 2023
Historique:
pmc-release: 01 07 2024
medline: 8 6 2023
pubmed: 16 5 2023
entrez: 16 5 2023
Statut: ppublish

Résumé

Hepatocytes produce bile components and secrete them into a lumen, known as a bile canaliculus, that is formed by the apical membranes of adjoining hepatocytes. Bile canaliculi merge to form tubular structures that subsequently connect to the canal of Hering and larger intra- and extrahepatic bile ducts formed by cholangiocytes, which modify bile and enable flow through the small intestine. The major functional requirements for bile canaliculi are the maintenance of canalicular shape to preserve the blood-bile barrier and regulation of bile flow. These functional requirements are mediated by functional modules, primarily transporters, the cytoskeleton, cell-cell junctions, and mechanosensing proteins. I propose here that bile canaliculi behave as robust machines whereby the functional modules act in a coordinated manner to perform the multistep task of maintaining canalicular shape and bile flow. Cholestasis, the general term for aberrant bile flow, stems from drug/toxin-induced or genetic dysregulation of one or more of the protein components in the functional modules. Here, I discuss the interactions between components of the various functional modules in bile canaliculi and describe how these functional modules regulate canalicular morphology and function. I use this framework to provide a perspective on recent studies of bile canalicular dynamics.

Identifiants

pubmed: 37192193
doi: 10.1152/ajpgi.00165.2022
pmc: PMC10259850
doi:

Types de publication

Journal Article Review Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

G14-G22

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK119290
Pays : United States

Références

Biochim Biophys Acta. 2005 Dec 30;1738(1-3):54-62
pubmed: 16332456
Gastroenterology. 2004 Nov;127(5):1386-90
pubmed: 15521008
Clin Liver Dis. 2008 Feb;12(1):1-26, vii
pubmed: 18242495
Nat Cell Biol. 2016 Mar;18(3):311-8
pubmed: 26878396
Front Med (Lausanne). 2020 Sep 11;7:544
pubmed: 33015098
Compr Physiol. 2013 Jul;3(3):1035-78
pubmed: 23897680
Hepatology. 2022 Feb;75(2):492-493
pubmed: 34543482
Nat Genet. 2014 Apr;46(4):326-8
pubmed: 24614073
Sci Rep. 2018 Feb 12;8(1):2818
pubmed: 29434311
J Biol Chem. 2007 Sep 21;282(38):28137-48
pubmed: 17623668
Hepatology. 2001 Jun;33(6):1460-8
pubmed: 11391535
Hepatology. 1995 Apr;21(4):1106-13
pubmed: 7705786
Cold Spring Harb Perspect Biol. 2017 Aug 1;9(8):
pubmed: 28213465
Gastroenterology. 2008 Mar;134(3):781-92
pubmed: 18325391
J Hepatol. 2009 Sep;51(3):565-80
pubmed: 19595470
Toxicol In Vitro. 2000 Apr;14(2):117-32
pubmed: 10793290
Gastroenterology. 2004 Aug;127(2):379-84
pubmed: 15300568
Cell Syst. 2017 Mar 22;4(3):277-290.e9
pubmed: 28330614
Pharmacogenet Genomics. 2007 Jan;17(1):47-60
pubmed: 17264802
Lab Invest. 1985 Sep;53(3):275-9
pubmed: 4033067
Drug Metab Dispos. 2016 Nov;44(11):1780-1793
pubmed: 27538918
Gastroenterology. 1999 Feb;116(2):401-10
pubmed: 9922322
Toxicol Sci. 2019 Jul 1;170(1):95-108
pubmed: 30985903
Sci Rep. 2014 Oct 30;4:6835
pubmed: 25355493
Hepatology. 2019 Feb;69(2):666-683
pubmed: 30102412
J Hepatol. 2017 Jun;66(6):1231-1240
pubmed: 28189756
Proc Natl Acad Sci U S A. 2014 Jan 21;111(3):1090-5
pubmed: 24395807
Theranostics. 2021 May 24;11(15):7262-7275
pubmed: 34158849
Hepatology. 2021 Apr;73(4):1531-1550
pubmed: 32558958
J Hepatol. 2003 Nov;39(5):864-74
pubmed: 14568273
J Hepatol. 2013 Jun;58(6):1201-8
pubmed: 23369794
J Lipid Res. 2006 Sep;47(9):1959-66
pubmed: 16741293
J Cell Biol. 2021 Oct 4;220(10):
pubmed: 34328499
Gastroenterology. 1999 Dec;117(6):1370-9
pubmed: 10579978
Gastroenterology. 1978 Sep;75(3):450-5
pubmed: 680500
Am J Physiol Gastrointest Liver Physiol. 2007 Mar;292(3):G905-12
pubmed: 17110522
Toxicology. 2001 Oct 5;167(1):83-98
pubmed: 11557132
BMC Pediatr. 2020 Aug 5;20(1):369
pubmed: 32758197
Gastroenterology. 2021 May;160(6):2103-2118
pubmed: 33465371
Hepatology. 2016 Mar;63(3):951-64
pubmed: 26610202
Nat Mater. 2020 Sep;19(9):1026-1035
pubmed: 32341512
J Hepatol. 2015 Dec;63(6):1440-8
pubmed: 26212029
Annu Rev Biophys Biomol Struct. 2004;33:75-93
pubmed: 15139805
Gastroenterology. 2002 Oct;123(4):1238-51
pubmed: 12360485
Elife. 2015 Dec 27;4:
pubmed: 26673893
Oncotarget. 2016 Dec 27;7(52):86985-86998
pubmed: 27895309
PLoS Biol. 2013 Dec;11(12):e1001739
pubmed: 24358023
Compr Physiol. 2013 Jan;3(1):515-39
pubmed: 23720295
Biomaterials. 2020 Nov;259:120283
pubmed: 32827796
Semin Cell Dev Biol. 2017 Nov;71:153-167
pubmed: 28768152
Ann Biomed Eng. 2005 May;33(5):696-708
pubmed: 15981869
Biochim Biophys Acta. 2007 Mar;1772(3):298-306
pubmed: 17204408
J Cell Biol. 2023 Apr 3;222(4):
pubmed: 36716168
Gastroenterology. 2001 May;120(6):1448-58
pubmed: 11313315
Proc Natl Acad Sci U S A. 2018 May 22;115(21):E4751-E4757
pubmed: 29735699

Auteurs

Kapish Gupta (K)

Division of Gastroenterology and Hepatology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
Center for Engineering MechanoBiology, The University of Pennsylvania, Philadelphia, Pennsylvania, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH